| Autor: |
Lu Y; Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, China., Zheng J; Department of Dentistry, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China., Lin P; Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, China., Lin Y; Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, China., Zheng Y; Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, China., Mai Z; Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, China., Chen X; Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, China., Xia T; Division of NanoMedicine, Department of Medicine, University of California Los Angeles, Los Angeles, California 90095, United States., Zhao X; Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, China., Cui L; Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, China.; School of Dentistry, University of California Los Angeles, Los Angeles, California 90095, United States. |
| Abstrakt: |
The tumor microenvironment (TME) plays a crucial role in cancer progression and immune evasion, partially mediated by the activity of the TME-derived exosomes. These extracellular vesicles are pivotal in shaping immune responses through the transfer of proteins, lipids, and nucleic acids between cells, facilitating a complex interplay that promotes tumor growth and metastasis. This review delves into the dual roles of exosomes in the TME, highlighting both their immunosuppressive functions and their emerging therapeutic potential. Exosomes can inhibit T cell function and promote tumor immune escape by carrying immune-modulatory molecules, such as PD-L1, yet they also hold promise for cancer therapy as vehicles for delivering tumor antigens and costimulatory signals. Additionally, the review discusses the intricate crosstalk mediated by exosomes among various cell types within the TME, influencing both cancer progression and responses to immunotherapies. Moreover, this highlights current challenges and future directions. Collectively, elucidating the detailed mechanisms by which TME-derived exosomes mediate T cell function offers a promising avenue for revolutionizing cancer treatment. Understanding these interactions allows for the development of targeted therapies that manipulate exosomal pathways to enhance the immune system's response to tumors. |
